Buy-rated reports

588 tickers rated Buy
Ranks this page's recent reports by score.
Matador Resources Company
MTDR·Energy
A ★★★★Buy
Current$51.60
Target$68.40
Return+32.6%
Aug 14, 2026

Matador is a highly efficient, deeply undervalued Delaware Basin compounder protected by a lucrative midstream moat, though investors must tolerate near-term cash flow volatility caused by regional natural gas pipeline bottlenecks.

Score
85
Credit Acceptance Corporation
CACC·Financials
A ★★★★Buy
Current$581.25
Target$677.60
Return+16.6%
Aug 14, 2026

Credit Acceptance possesses an unassailable, high-yield niche in subprime auto lending protected by risk-sharing dealer contracts, trading at a deeply discounted multiple despite generating massive cash flows, though investors must tolerate the inherent volatility of subprime consumer delinquency cycles.

Score
88
Hinge Health, Inc.
HNGE·Healthcare
A ★★★★Buy
Current$86.32
Target$110.00
Return+27.4%
Aug 14, 2026

Hinge Health is the fundamentally dominant, wildly profitable pioneer of the digital musculoskeletal care revolution, poised to capture immense cross-selling upside through its GI expansion, though investors must monitor the intense competitive pricing threats from well-capitalized rivals like Sword Health.

Score
85
InterDigital, Inc.
IDCC·Technology
A ★★★★Buy
Current$348.25
Target$462.67
Return+32.9%
Aug 14, 2026

InterDigital is a highly profitable, patent-rich tollbooth for global 5G/6G and video technologies, positioned for significant recurring revenue growth through automotive and cloud expansion, though its premium valuation demands consistent execution against implementer hold-out risks.

Score
88
Gates Industrial Corporation plc
GTES·Industrials
A ★★★★Buy
Current$27.86
Target$33.45
Return+20.1%
Aug 13, 2026

Gates Industrial is a highly profitable, cash-gushing compounder leveraging its dominant aftermarket position to shield against industrial cyclicality, while an emerging structural growth catalyst in data center liquid cooling provides powerful, unexpected upside to its fundamentally cheap valuation.

Score
86
Camtek Ltd.
CAMT·Technology
A ★★★★Buy
Current$174.20
Target$202.50
Return+16.2%
Aug 13, 2026

Camtek is the highly profitable, indispensable tollbooth for the global AI and HBM packaging supercycle, trading at a relative discount to its direct peers, though investors must vigilantly monitor the intense regulatory risks associated with its massive Chinese revenue exposure.

Score
88
F.N.B. Corporation
FNB·Financials
A ★★★★Buy
Current$19.11
Target$21.00
Return+9.9%
Aug 13, 2026

F.N.B. is a highly disciplined, vastly undervalued regional banking powerhouse driving elite 14% returns on tangible equity through structural margin expansion and aggressive share repurchases, though investors must monitor systemic risks tied to commercial real estate refinancing cycles.

Score
87
AutoNation, Inc.
AN·Consumer Discretionary
A ★★★★Buy
Current$209.23
Target$259.56
Return+24.1%
Aug 13, 2026

AutoNation presents a deeply undervalued, highly defensive capital return compounder, insulated by its lucrative After-Sales monopoly and massive share buybacks, though investors must monitor the credit quality of its rapidly scaling captive finance portfolio.

Score
88
Liquidia Corporation
LQDA·Healthcare
A ★★★★Buy
Current$79.79
Target$117.20
Return+46.9%
Aug 13, 2026

Liquidia is successfully leveraging its proprietary, highly precise PRINT technology to aggressively disrupt a multi-billion-dollar cardiopulmonary monopoly, driving explosive revenue growth and massive margin expansion, though investors must remain hyper-vigilant regarding the intense commercial and pricing retaliation from the incumbent legacy competitor.

Score
88
Ferguson Enterprises Inc.
FERG·Industrials
A ★★★★Buy
Current$263.78
Target$297.60
Return+12.8%
Aug 13, 2026

Ferguson is a fiercely dominant, highly localized industrial distributor capitalizing on the US infrastructure and data center supercycle, offering investors a uniquely discounted entry point relative to distribution peers despite facing lingering headwinds in the macro housing market.

Score
89
Simon Property Group, Inc.
SPG·Real Estate
A ★★★★Buy
Current$220.55
Target$245.12
Return+11.1%
Aug 13, 2026

Simon Property is the undisputed, cash-gushing apex predator of Class-A retail real estate, leveraging immense pricing power and brilliant capital recycling to fund high-yield densification, though investors must monitor the friction of a $28.7 billion debt load in a restrictive rate environment.

Score
88
Praxis Precision Medicines, Inc.
PRAX·Healthcare
A ★★★★Buy
Current$370.00
Target$615.00
Return+66.2%
Aug 13, 2026

Praxis is poised to monopolize a stagnant multi-billion dollar essential tremor market and a high-margin pediatric epilepsy market through first-in-class precision neurology, trading at an attractive forward valuation, though investors must remain hyper-vigilant regarding binary FDA approval decisions and the complexities of commercial payer negotiations.

Score
88
Roivant Sciences Ltd.
ROIV·Healthcare
A ★★★★Buy
Current$36.34
Target$44.00
Return+21.1%
Aug 13, 2026

Roivant offers a formidable hub-and-spoke biopharma pipeline armed with a massive $4.7 billion liquidity moat, entirely eliminating dilution risk while it advances potentially best-in-class immunology assets toward imminent commercialization.

Score
91
NIQ Global Intelligence plc
NIQ·Technology
A ★★★★Buy
Current$16.58
Target$19.80
Return+19.4%
Aug 13, 2026

NIQ possesses an unbreakable, monopolistic data moat tracking $7.4 trillion in consumer spend, generating massive free cash flow at an absurdly cheap 13x forward multiple, though investors must navigate the technical volatility of impending private equity secondary stock sales.

Score
90
Alcon Inc.
ALC·Healthcare
A ★★★★Buy
Current$75.35
Target$95.34
Return+26.5%
Aug 13, 2026

Alcon is the undisputed, highly profitable tollbooth of the global ophthalmic surgery market, trading at a compelling forward discount driven by its Unity platform supercycle, though investors must monitor the margin impact of protectionist U.S. import tariffs and intense premium IOL competition.

Score
86
Embraer S.A.
EMBJ·Industrials
A ★★★★Buy
Current$73.96
Target$93.50
Return+26.4%
Aug 13, 2026

Backed by a record $34.5 billion backlog and soaring free cash flow, Embraer is a fiercely executing aerospace powerhouse trading at a deep discount to peers, though investors must vigilantly monitor lingering U.S. tariff pressures and Pratt & Whitney supply chain bottlenecks.

Score
89
Essential Properties Realty Trust, Inc.
EPRT·Real Estate
A ★★★★Buy
Current$30.63
Target$34.51
Return+12.7%
Aug 13, 2026

Essential Properties is a masterfully fortified tollbooth on the middle-market service economy, leveraging immense data transparency and master leases to deliver peer-leading 8% growth.

Score
91
Chord Energy Corporation
CHRD·Energy
A ★★★★Buy
Current$139.23
Target$164.85
Return+18.4%
Aug 13, 2026

Chord Energy dominates the Williston Basin as a hyper-efficient, cash-gushing E&P trading at a massive valuation discount, though investors must tolerate the inescapable macro volatility of global crude pricing.

Score
91
First American Financial Corporation
FAF·Financials
A ★★★★Buy
Current$74.24
Target$86.52
Return+16.5%
Aug 12, 2026

First American Financial is an unassailable, highly profitable tollbooth on U.S. real estate transactions trading at a deeply compressed 10.2x forward multiple, though investors must endure the cyclical volatility of a paralyzed residential housing market dictated by Federal Reserve policy.

Score
91
Healthcare Realty Trust Incorporated
HR·Real Estate
A ★★★★Buy
Current$19.64
Target$23.78
Return+21.1%
Aug 12, 2026

Healthcare Realty provides an impenetrable, inflation-resistant infrastructure moat anchored to America's top hospital campuses, trading at a severely dislocated valuation that ignores its elite cash-flow growth, though investors must monitor the ongoing margin pressures facing the broader hospital sector.

Score
90
Avantor, Inc.
AVTR·Healthcare
A ★★★★Buy
Current$13.73
Target$16.40
Return+19.4%
Aug 12, 2026

Avantor is a deeply discounted, highly cash-generative tollbooth on the global life sciences industry, offering immense turnaround upside as pandemic-era destocking normalizes, though near-term execution risks surrounding its restructuring demand patience.

Score
89
Lithia Motors, Inc.
LAD·Consumer Discretionary
A ★★★★Buy
Current$375.63
Target$440.00
Return+17.1%
Aug 12, 2026

Lithia Motors is rapidly transitioning from a cyclical auto dealer into a highly profitable, omnichannel mobility ecosystem powered by a lucrative aftersales monopoly and a surging captive finance arm, trading at an entirely unwarranted discount despite executing one of the market's most aggressive, value-accretive share cannibalization programs.

Score
90
National Fuel Gas Company
NFG·Utilities
A ★★★★Buy
Current$80.54
Target$97.50
Return+21.1%
Aug 12, 2026

National Fuel is executing a highly accretive, masterfully engineered transformation into a premier, geographically diversified regulated utility, offering investors a uniquely mispriced 11.3x forward earnings multiple and a bulletproof dividend, though vigilant monitoring of the $2.62 billion Ohio integration and New York regulatory hostility is strictly required.

Score
90
Rush Street Interactive, Inc.
RSI·Consumer Discretionary
A ★★★★Buy
Current$25.15
Target$37.50
Return+49.1%
Aug 12, 2026

Rush Street Interactive is leveraging a vastly superior, structurally high-margin iCasino strategy to mint cash and dominate Latin America, though investors must diligently monitor the regulatory volatility and the structural cash-drain of the TRA liability inherent to its expansion.

Score
90